Investor profile
Advent France Biotechnology has backed 4 European tech companies across 4 funding rounds between 2019 and 2021, joining rounds totalling €34M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Agomab Therapeutics | Belgium | 1 | €21M |
| Integra Therapeutics | Spain | 1 | €4.5M |
| Arthex Biotech | Spain | 1 | €4.3M |
| Agalaia Therapeutics | France | 1 | €4.0M |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Agomab Therapeutics | Series A | €21M | 2019-04 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Arthex Biotech | Seed | €4.3M | 2020-07 |
| Agalaia Therapeutics |
| Seed |
| €4.0M |
| 2021-09 |
